Total Current Liabilities - Nanobiotix SA (PAR:NANO) - Alpha Spread

Nanobiotix SA
PAR:NANO

Watchlist Manager
Nanobiotix SA Logo
Nanobiotix SA
PAR:NANO
Watchlist
Price: 4.584 EUR -1.33%
Market Cap: 217.3m EUR
Have any thoughts about
Nanobiotix SA?
Write Note

Nanobiotix SA
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nanobiotix SA
Total Current Liabilities Peer Comparison

Comparables:
VLA
IPH
GNFT
ALERS
OSE

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Nanobiotix SA
PAR:NANO
Total Current Liabilities
€49.9m
CAGR 3-Years
38%
CAGR 5-Years
34%
CAGR 10-Years
31%
Valneva SE
PAR:VLA
Total Current Liabilities
€102.5m
CAGR 3-Years
-39%
CAGR 5-Years
21%
CAGR 10-Years
15%
Innate Pharma SA
PAR:IPH
Total Current Liabilities
€38.2m
CAGR 3-Years
-4%
CAGR 5-Years
-17%
CAGR 10-Years
12%
Genfit SA
NASDAQ:GNFT
Total Current Liabilities
€38.5m
CAGR 3-Years
7%
CAGR 5-Years
0%
CAGR 10-Years
16%
Eurobio Scientific SA
PAR:ALERS
Total Current Liabilities
€52.9m
CAGR 3-Years
3%
CAGR 5-Years
17%
CAGR 10-Years
18%
OSE Immunotherapeutics SA
PAR:OSE
Total Current Liabilities
€18.8m
CAGR 3-Years
10%
CAGR 5-Years
16%
CAGR 10-Years
N/A

See Also

What is Nanobiotix SA's Total Current Liabilities?
Total Current Liabilities
49.9m EUR

Based on the financial report for Dec 31, 2023, Nanobiotix SA's Total Current Liabilities amounts to 49.9m EUR.

What is Nanobiotix SA's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
31%

Over the last year, the Total Current Liabilities growth was 31%. The average annual Total Current Liabilities growth rates for Nanobiotix SA have been 38% over the past three years , 34% over the past five years , and 31% over the past ten years .

Back to Top